Pricing Log in Create free account

Autolus Therapeutics PLC Sponsored ADR (AUTL) vs Ovid Therapeutics (OVID)

Autolus Therapeutics PLC Sponsored ADR and Ovid Therapeutics are both Biotechnology companies. Autolus Therapeutics PLC Sponsored ADR and Ovid Therapeutics are of similar size ($481.8M and $480.4M). Ovid Therapeutics grew revenue faster over the last twelve months: 1,333.4% against 193.3%. Autolus Therapeutics PLC Sponsored ADR has the higher net margin (−238.7% vs −439.1%) and the higher return on invested capital (0.00% vs −35.1%). Across the 18 metrics below, Ovid Therapeutics leads on 10 and Autolus Therapeutics PLC Sponsored ADR on 8.

Valuation

Metric AUTL OVID Biotechnology median
P/E n/m n/m 8.56
P/S 3.95 60.58 10.17
P/B 6.19 2.27 2.34
Price to free cash flow n/m n/m 20.42
EV/EBITDA n/m n/m 0.69
EV/Sales 2.88 47.09 9.64
Earnings yield (60.92%) (9.35%) (29.41%)
Free cash flow yield (54.82%) (11.54%) (23.50%)

Profitability

Metric AUTL OVID Biotechnology median
Gross margin 15.66% 100.00% 65.16%
Operating margin (210.78%) (742.97%) 0.00%
Net margin (238.66%) (439.11%) 0.00%
Free cash flow margin (198.26%) (697.30%) 0.00%
Return on equity (133.00%) (25.97%) (56.66%)
Return on assets (46.15%) (22.30%) (49.22%)
Return on invested capital 0.00% (35.11%) 0.00%

Growth

Metric AUTL OVID Biotechnology median
Revenue growth (TTM) 193.29% 1,333.39% 5.64%
EPS growth (last fiscal year) (25.58%) 37.84% 30.08%
Revenue growth, 5-year CAGR 113.11% (10.48%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AUTL OVID Biotechnology median
Debt to equity 1.04 0.05 0.00
Current ratio 4.89 12.39 4.72
Net debt to EBITDA 1.16 1.37 0.96

Dividend

Metric AUTL OVID Biotechnology median
Dividend yield — — 0.08%
Payout ratio — — —

Size

Metric AUTL OVID Biotechnology median
Market cap 481.75m 480.43m 151.40m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack